Extreme genetic risk for type 1A diabetes

被引:162
|
作者
Aly, Theresa A.
Ide, Akane
Jahromi, Mohamed M.
Barker, Jennifer M.
Fernando, Maria S.
Babu, Sunanda R.
Yu, Liping
Miao, Dongmei
Erlich, Henry A.
Fain, Pamela R.
Barriga, Katherine J.
Norris, Jill M.
Rewers, Marian J.
Eisenbarth, George S. [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA
[2] Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Aurora, CO 80045 USA
[3] Roche Mol Syst, Alameda, CA 94501 USA
[4] Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA
[5] Hlth Sci Ctr, Denver, CO 80262 USA
关键词
haplotype; human leukocyte antigen; major histocompatibility complex;
D O I
10.1073/pnas.0606349103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 1 A diabetes (T1D) is an autoimmune disorder the risk of which is increased by specific HLA DR/DQ alleles [e.g., DRB1*03-DQB1*0201 (DR3) or DRB1*04-DQB1*0302 (DR4)]. The genotype associated with the highest risk for T1D is the DR3/4-DQ8 (DQ8 is DQA1*0301, DQB1*0302) heterozygous genotype. We determined HLA-DR and -DQ genotypes at birth and analyzed DR3/4-DQ8 siblings of patients with T1D for identical-by-descent HLA haplotype sharing (the number of haplotypes inherited in common between siblings). The children were clinically followed with prospective measurement of anti-islet autoimmunity and for progression to T1D. Risk for islet autoimmunity dramatically increased in DR3/4-DQ8 siblings who shared both HLA haplotypes with their diabetic proband sibling (63% by age 7, and 85% by age 15) compared with siblings who did not share both HLA haplotypes with their diabetic proband sibling (20% by age 15, P < 0.01). 55% sharing both HILA haplotypes developed diabetes by age 12 versus 5% sharing zero or one haplotype (P = 0.03). Despite sharing both HILA haplotypes with their proband, siblings without the HILA DR3/4-DQ8 genotype had only a 25% risk for T1D by age 12. The risk for T1D in the DR3/4-DQ8 siblings sharing both HILA haplotypes with their proband is remarkable for a complex genetic disorder and provides evidence that T1D is inherited with HLA-DR/DQ alleles and additional MHC-linked genes both determining major risk. A subset of siblings at extremely high risk for T1D can now be identified at birth for trials to prevent islet autoimmunity.
引用
收藏
页码:14074 / 14079
页数:6
相关论文
共 50 条
  • [21] Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention
    Redondo, Maria J.
    Bundy, Brian N.
    Parikh, Hemang M.
    You, Lu
    Triolo, Taylor M.
    Ferrat, Lauric A.
    Templeman, Erin
    Tosur, Mustafa
    Steck, Andrea
    Gottlieb, Peter
    Onengut-Gumuscu, Suna
    Rich, Stephen S.
    Oram, Richard A.
    Herold, Kevan C.
    Krischer, Jeffrey
    DIABETES, 2024, 73
  • [22] Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes
    Patel, Kashyap A.
    Oram, Richard A.
    Flanagan, Sarah E.
    De Franco, Elisa
    Colclough, Kevin
    Shepherd, Maggie
    Ellard, Sian
    Weedon, Michael N.
    Hattersley, Andrew T.
    DIABETES, 2016, 65 (07) : 2094 - 2099
  • [23] A genetic approach for studying the physiology of the type 1A (AT(1A)) angiotensin receptor
    Coffman, TM
    SEMINARS IN NEPHROLOGY, 1997, 17 (05) : 404 - 411
  • [24] Type 1 diabetes genetic risk score: a novel tool to differentiate monogenic diabetes from Type 1 diabetes
    Patel, K. A.
    Weedon, M. N.
    Ellard, S.
    Hattersley, A. T.
    Oram, R. A.
    DIABETIC MEDICINE, 2015, 32 : 21 - 22
  • [25] A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk
    Redondo, M. J.
    Geyer, S.
    Steck, A. S.
    Sharp, S.
    Wentworth, J.
    Weedon, M.
    Antinozzi, P.
    Pugliese, A.
    Oram, R.
    DIABETOLOGIA, 2017, 60 : S25 - S25
  • [26] A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk
    Redondo, Maria J.
    Geyer, Susan
    Steck, Andrea K.
    Sharp, Seth
    Wentworth, John M.
    Weedon, Michael N.
    Antinozzi, Peter
    Sosenko, Jay
    Atkinson, Mark
    Pugliese, Alberto
    Oram, Richard A.
    DIABETES CARE, 2018, 41 (09) : 1887 - 1894
  • [27] Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes
    Azam, A
    Eisenbarth, GS
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (10) : 1569 - 1575
  • [28] Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
    Redondo, Maria J.
    Oram, Richard A.
    Steck, Andrea K.
    CURRENT DIABETES REPORTS, 2017, 17 (12)
  • [29] Genetic and perinatal factors as risk for childhood type 1 diabetes
    Larsson, K
    Elding-Larsson, H
    Cederwall, E
    Kockum, K
    Sjöblad, S
    Lindberg, B
    Lernmark, B
    Cilio, C
    Ivarsson, SA
    Lernmark, Å
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2004, 20 (06) : 429 - 437
  • [30] Genetic Risk Factors for Kidney Disease in Type 1 Diabetes
    Limonte, Christine P.
    Gao Xiaoyu
    Bebu, Ionut
    Karger, Amy B.
    Lorenzi, Gayle
    Perkins, Bruce A.
    De Boer, Ian
    Paterson, Andrew
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):